This FABP4/UCP2 axis was enriched in adipocyte-rich tumour microenvironments and correlated with increased stemness and mesenchymal traits in persisted cells, which could be reversed by the FABP4 inhibitor BMS309403 [105]. This evidence concerns the gene FABP4 and neoplasm.